Securities fraud litigation history and active cases
In Litigation
2
Settlement
0
Closed
0
Total Settlement
$0
3:26cv2317 • March 5, 2026
Class Period Start
June 16, 2025
Class Period End
January 8, 2026
PSLRA Deadline
May 4, 2026
Case Allegations
10b5
Statutes of Repose
Jun 16, 2028
Country
United States
Court
Federal Court
3:21cv3751 • March 1, 2021
Class Period Start
August 7, 2019
Class Period End
September 25, 2020
PSLRA Deadline
April 30, 2021
Case Allegations
10b5
Statutes of Repose
Aug 7, 2022
Country
United States
Court
Federal Court
Apr 7, 2023
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Mar 14, 2023
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Aug 16, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jun 25, 2021
A new complaint has been filed on behalf of certain investors in Aquestive Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
TOP